Eye-Tracking glasses may reveal how children with cerebral palsy coordinate gaze and hands

NCT ID NCT07806994

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Sep 08, 2026 · Last updated Sep 09, 2026 · Updated 1 time

Summary

This observational pilot study tests whether wearable eye-tracking glasses can reliably record gaze during two-handed tasks in children aged 6 to 12 years, including 20 with cerebral palsy and 20 with typical development. Each child attends one session, wears the glasses, and performs tasks like finding and placing objects under varying visual and sequencing demands. Researchers will check if the setup and recordings work well and explore how gaze and hand actions relate. No treatment is given; the goal is to improve measurement methods for future studies.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Wearable eye-tracking assessment during structured bimanual tasks
What this could lead to
If successful, this could establish a reliable method to measure how children with cerebral palsy coordinate gaze and hand actions, supporting future research and therapy planning.
What could go wrong
This is a small pilot study focused on feasibility, not treatment. The eye-tracking device may not work well in all children, and results may not apply beyond this specific protocol.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 40 people

The number the study aims to enrol. It can still change while the study runs.

Started

Aug 2026

Expected to finish

Aug 2027

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

6 to 12 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria General Inclusion Criteria Children aged 6-12 years * Ability to understand simple instructions required for the study procedures and perform structured visual and bimanual tasks * For children who routinely wear glasses or contact lenses, ability to view near visual stimuli and task materials with their habitual vision correction * Written informed consent provided by a parent or legally authorized representative, with the child providing assent after receiving an age- and developmentally appropriate explanation of the study Cerebral Palsy Group * Diagnosis of cerebral palsy confirmed by a pediatric physiatrist * Manual Ability Classification System (MACS) level I-III * Ability to grasp or manipulate task materials with at least one hand and attempt bimanual task performance Typically Developing Group * Typical developmental history based on parent report and confirmation by the research team * No history of neurological disorders, including cerebral palsy, or musculoskeletal conditions affecting upper-limb function * No diagnosis of a neurodevelopmental disorder that may affect task performance, such as attention-deficit/hyperactivity disorder, autism spectrum disorder, or intellectual disability Exclusion Criteria * Visual impairment that prevents the child from adequately viewing near visual stimuli or task materials, even with habitual vision correction * Severe strabismus, nystagmus, or another ophthalmologic condition judged likely to substantially compromise stable eye-tracking data collection * Severe cognitive, communication, or behavioral difficulties that prevent adequate understanding or performance of the study tasks * Severe upper-limb joint contracture, pain, fracture, or another musculoskeletal condition that prevents safe performance of the bimanual tasks * Uncontrolled epilepsy, acute illness, unstable medical condition, or any other condition judged to make study participation unsafe

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Cerebral palsy (CP) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Samsung Medical Center

    RECRUITING

    Seoul, Seoul, 06351, South Korea

More trials for these conditions

Other studies related to the condition(s) this trial covers.